Concepedia

Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy

Yasmina Chouik, Domitille Erard, H. Demian, Thomas F. Schulz, Tessa Mazard, Kerstin Hartig-Lavie, Térésa Antonini, Jean‐Yves Mabrut, Kayvan Mohkam, Agnès Rode,

Frontiers in Immunology · 2023 · 29 citations · 8 references

DOIFull text

Open access

Abstract

Atezolizumab/Bevacizumab therapy may enable complete pathological response of advanced HCC. Safety of prolonged treatment need to be assessed.

References

8

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn, Shukui Qin, Masafumi Ikeda et al. · New England Journal of Medicine · 2020 · 6.8K citations · Full text

Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?

Mina F. Nordness, Stephanie Hamel, Caroline M. Godfrey et al. · American Journal of Transplantation · 2019 · 159 citations · Full text

Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma

Parissa Tabrizian, Matthew L. Holzner, Neil Mehta et al. · JAMA Surgery · 2022 · 136 citations · Full text

Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium

Neil Mehta, Catherine Frenette, Parissa Tabrizian et al. · Gastroenterology · 2021 · 136 citations · Full text

, , +9

Immunotherapy as a Downstaging Therapy for Liver Transplantation

Birgit Schwacha‐Eipper, Iulia Minciună, Vanessa Banz et al. · Hepatology · 2020 · 106 citations

, , +18